Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) EBT Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) EBT Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 15.41%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 9.13%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 23.53%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -18.40%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 29.23%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 31.30%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 30.27%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 72.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.13%
Mar 31, 2026 6.44%
Dec 31, 2025 44.66%
Sep 30, 2025 -2.23%
Jun 30, 2025 5.94%
Mar 31, 2025 -15.16%
Dec 31, 2024 -15.86%
Sep 30, 2024 -23.22%
Jun 30, 2024 -27.29%
Mar 31, 2024 -24.82%
Dec 31, 2023 -32.13%
Sep 30, 2023 -26.50%
Jun 30, 2023 7.52%
Mar 31, 2023 32.90%
Dec 31, 2022 -30.73%
Sep 30, 2022 9.14%
Jun 30, 2022 6.82%
Mar 31, 2022 28.50%
Dec 31, 2021 44.32%
Sep 30, 2021 34.97%